1 reports of this reaction
12.5% of all PAIN RELIEF PATCH reports
#1 most reported adverse reaction
APPLICATION SITE ERYTHEMA is the #1 most commonly reported adverse reaction for PAIN RELIEF PATCH, manufactured by Bionpharma Inc.. There are 1 FDA adverse event reports linking PAIN RELIEF PATCH to APPLICATION SITE ERYTHEMA. This represents approximately 12.5% of all 8 adverse event reports for this drug.
Patients taking PAIN RELIEF PATCH who experience application site erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
APPLICATION SITE ERYTHEMA is a frequently reported adverse event for PAIN RELIEF PATCH, accounting for a significant proportion of all reports.
In addition to application site erythema, the following adverse reactions have been reported for PAIN RELIEF PATCH:
The following drugs have also been linked to application site erythema in FDA adverse event reports:
APPLICATION SITE ERYTHEMA has been reported as an adverse event in 1 FDA reports for PAIN RELIEF PATCH. This does not prove causation, but indicates an association observed in post-market surveillance data.
APPLICATION SITE ERYTHEMA accounts for approximately 12.5% of all adverse event reports for PAIN RELIEF PATCH, making it one of the most commonly reported side effect.
If you experience application site erythema while taking PAIN RELIEF PATCH, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.